Clinical trials
Phase 3 Carcinoma, Ovarian Epithelial trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2011 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| pharmaand GmbH | 3 |
| AbbVie | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Daiichi Sankyo | 1 |
| ImmunoGen, Inc. | 1 |
| MEI Pharma, Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Novartis Pharmaceuticals | 1 |
| Vascular Biogenics Ltd. operating as VBL Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 12 |
| Fallopian Tube Neoplasms | 9 |
| Ovarian Neoplasms | 9 |
| Neoplasms | 2 |
| Peritoneal Neoplasms | 2 |
| Recurrence | 2 |
| Genital Neoplasms, Male | 1 |
| Pathologic Complete Response | 1 |
| Prostatic Neoplasms | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.